Share on LinkedInShare on LinkedIn

ARTICLE · 12 JUNE 2007

Securities And Banking Update - Weighing Up The Options

There has been much discussion over the impact of the Markets in Financial Instruments Directive (“MiFID”), particularly the application of the Best Execution requirements. Much of this focus has centred on the application of best execution to OTC products and how best execution is demonstrated in situations where the products are closely tailored to client requirements or are traded by a limited number of firms.

United KingdomFinance and Banking

There has been much discussion over the impact of the Markets in Financial Instruments Directive ("MiFID"), particularly the application of the Best Execution requirements. Much of this focus has centred on the application of best execution to OTC products and how best execution is demonstrated in situations where the products are closely tailored to client requirements or are traded by a limited number of firms. One of the other more complex areas of the best execution requirements will be their application in dealer markets. There has been some guidance issued through the consultation papers from the FSA and from industry and trade associations, however the FSA has yet to state its final views.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from